Home/Sponsorship/Meet our Sponsors

MEET OUR SPONSORS

DIAMOND

National Cancer Institute (NCI) is part of the NIH, one of 11 agencies that are part of the U.S. Department of Health and Human Services. NCI coordinates the U.S. National Cancer Program, which conducts and supports research, training, health information dissemination and other activities related to the cause, prevention, diagnosis, and treatment of cancer; cancer survivorship; and the continuing care of cancer patients and their families.
NCI, Center for Global Health (CGH) supports the NCI mission by advancing global cancer research and coordinating NCI engagement in global cancer control. CGH also represents NCI in international research partnerships, playing a key role in coordinating multinational research efforts for global benefit. Core values for CGH are impact, equity, and collaboration. These values inform CGH efforts to lead innovative, impactful programs with partners within and outside NCI. CGH goals are focused on research, research training, dissemination, and partnership, primarily in low- and middle-income countries (LMICs). Areas of scientific focus include new technologies, implementation science, cancer health disparities, clinical trials, and cancer etiology.
Visit  www.cancer.gov  for further information.

SILVER

Varian is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Visit www.varian.com for more information.

BRONZE

Visit www.cancer.org for further information.

BRONZE

The mission of the Bristol Myers Squibb Foundation is to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases by strengthening healthcare worker capacity, integrating medical care and community-based supportive services and mobilizing communities in the fight against disease.
The Foundation’s Global Cancer Disparities Initiative seeks to strengthen cancer care systems and community supportive services for heavily burdened populations facing a range of pediatric and adult cancers in sub–Saharan Africa, Brazil, China and the US.
Visit www.bms.com/foundation for further information.

SUPPORTER

City Cancer Challenge Foundation (C/Can) supports cities around the world as they work to improve access to equitable, quality cancer care. C/Can leads a city-based partnership initiative that aims to improve access to quality cancer care in cities around the world by transforming the way stakeholders from the public and private sectors collectively design, plan, and implement cancer solutions.

The approach is built on the core principle that cities can drive impact at a national level by crafting data-driven solutions with the support of a network of global, regional, and local partners that reflect an understanding of the unique local context. C/Can was launched by the Union for International Cancer Control (UICC) at the 2017 World Economic Forum Annual Meeting in Davos. It was established as a standalone Swiss foundation in January 2019.

Visit www.citycancerchallenge.org for further information.